Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 8:18 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 193–216 of 361 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Tumor markers Clear all

Conditions: Breast Cancer
Interventions: Cardiac Magnetic Resonance Imaging (CMR), Echocardiogram (ECHO); Other
Lead sponsor: Beth Israel Deaconess Medical Center; Other
Eligibility: 18 Years and older · Female only
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2024
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Tumors
Interventions: Dasatinib + Ketoconazole; Drug
Lead sponsor: Bristol-Myers Squibb; Industry
Eligibility: 18 Years and older
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2007
U.S. locations: 4
States / cities: Santa Monica, California • Tampa, Florida • Nashville, Tennessee + 1 more

Conditions: Thyroid Cancer
Interventions: Not listed
Lead sponsor: OHSU Knight Cancer Institute; Other
Eligibility: 1 Year and older
Enrollment: 847 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2010
U.S. locations: 1
States / cities: Portland, Oregon

Conditions: Cancer Cachexia
Interventions: Eicosapentaenoic Acid; Drug
Lead sponsor: H. Lee Moffitt Cancer Center and Research Institute; Other
Eligibility: 25 Years to 80 Years
Enrollment: 36 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2010
U.S. locations: 2
States / cities: Stuart, Florida • Tampa, Florida

Conditions: Breast Cancer, Glioma, Hepatocellular Cancer, Squamous Cell Lung Cancer, Pancreatic Cancer, Colon Cancer, Prostate Cancer
Interventions: Autologous Natural Killer / Natural Killer T Cell Immunotherapy; Biological
Lead sponsor: Envita Medical Center, Inc.; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2009
U.S. locations: 1
States / cities: Scottsdale, Arizona

Conditions: Personalized Medicine, Oligometastatic Disease, Feasibility
Interventions: Darwin OncoTarget and OncoTreat; Diagnostic Test
Lead sponsor: Good Samaritan Hospital Medical Center, New York; Other
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: West Islip, New York

Conditions: Bladder Cancer, Hematuria
Interventions: AssureMDx; Diagnostic Test
Lead sponsor: MDx Health; Industry
Eligibility: 40 Years to 85 Years
Enrollment: 1,148 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2020
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Prostate Cancer
Interventions: Dovitinib, Abiraterone Acetate, Prednisone; Drug
Lead sponsor: M.D. Anderson Cancer Center; Other
Eligibility: 18 Years and older · Male only
Enrollment: 4 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2017
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Anatomic Stage IV Breast Cancer AJCC v8, Estrogen Receptor Positive, HER2/Neu Negative, Progesterone Receptor Positive, Prognostic Stage IV Breast Cancer AJCC v8, Elevated CA15-3 or CEA or CA27-29
Interventions: Usual care disease monitoring, Serum Tumor Marker directed disease monitoring, Quality-of-Life Assessment, Anxiety Questionnaire Administration; Other
Lead sponsor: SWOG Cancer Research Network; Network
Eligibility: 18 Years and older
Enrollment: 739 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2033
U.S. locations: 709
States / cities: Anchorage, Alaska • Fairbanks, Alaska • Kingman, Arizona + 456 more

Conditions: Chronic Hepatitis C, Chronic Hepatitis B
Interventions: Regression of fibrosis, Specific risk factors related to hepatocellular carcinoma; Other
Lead sponsor: University of Arkansas; Other
Eligibility: 18 Years to 70 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2019
U.S. locations: 2
States / cities: Little Rock, Arkansas • Chapel Hill, North Carolina

Conditions: Metastatic Breast Cancer, Triple Negative Breast Cancer
Interventions: Not listed
Lead sponsor: US Oncology Research; Industry
Eligibility: 18 Years and older · Female only
Enrollment: 14 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2013
U.S. locations: 18
States / cities: Denver, Colorado • Elizabeth City, North Carolina • Portland, Oregon + 11 more

Conditions: Carcinomas (Including Squamous Cell and Adenocarcinoma), Neoplasms
Interventions: blood draw; Procedure
Lead sponsor: Stanford University; Other
Eligibility: 18 Years and older
Enrollment: 2,000 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2002 – 2032
U.S. locations: 1
States / cities: Stanford, California

Conditions: Breast Neoplasm Female, Ultrasound Therapy; Complications
Interventions: Research Marker; Device
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years and older · Female only
Enrollment: 8 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2022
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Breast Cancer, Obesity, Hypovitaminosis D
Interventions: Vitamin D, Placebo; Dietary Supplement
Lead sponsor: Fred Hutchinson Cancer Center; Other
Eligibility: 50 Years to 75 Years · Female only
Enrollment: 218 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2012
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Breast Cancer
Interventions: Not listed
Lead sponsor: National Cancer Institute (NCI); NIH
Eligibility: 15 Years and older · Female only
Enrollment: 2,632 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2004
U.S. locations: 1
States / cities: Frederick, Maryland

Conditions: Breast Cancer, Morbid Obesity, Bariatric Surgery Candidate
Interventions: Bariatric surgery; Procedure
Lead sponsor: The Cleveland Clinic; Other
Eligibility: 40 Years to 74 Years · Female only
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2023
U.S. locations: 1
States / cities: Weston, Florida

Conditions: CRC (Colorectal Cancer)
Interventions: cfDNA 5mC/5hmC Sequencing (EpiCORE Discovery Phase), EpiCORE Assay (Targeted Sequencing / qPCR Validation); Diagnostic Test
Lead sponsor: City of Hope Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 600 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2028
U.S. locations: 1
States / cities: Duarte, California

Conditions: Hematopoietic/Lymphoid Cancer, Unspecified Adult Solid Tumor, Protocol Specific, Unspecified Childhood Solid Tumor, Protocol Specific
Interventions: Not listed
Lead sponsor: Rutgers, The State University of New Jersey; Other
Eligibility: Not listed
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2006
U.S. locations: 1
States / cities: New Brunswick, New Jersey

Conditions: Breast Cancer, Metastatic Breast Cancer
Interventions: Prolonged Nightly Fasting, Exercise; Behavioral
Lead sponsor: Dana-Farber Cancer Institute; Other
Eligibility: 18 Years and older · Female only
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2024
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Muscle Invasive Bladder Urothelial Carcinoma, Esophageal Cancer, Gastric and Gastroesophageal Junction (GEJ) Adenocarcinoma, Melanoma (Skin Cancer), NSCLC (Non-small Cell Lung Cancer), Pancreatic (Exocrine Only), Mix of Solid Tumors (MOST)
Interventions: blood and tissue samples, blood and tissue samples; Diagnostic Test · Other
Lead sponsor: Paradigm Health; Industry
Eligibility: 18 Years and older
Enrollment: 1,350 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2032
U.S. locations: 47
States / cities: Birmingham, Alabama • Bullhead City, Arizona • Casa Grande, Arizona + 43 more

Conditions: Resectable Pancreatic Adenocarcinoma
Interventions: Pancreatic cancer microRNA and messenger RNA expression.; Other
Lead sponsor: University of Oklahoma; Other
Eligibility: 18 Years and older
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2026
U.S. locations: 1
States / cities: Oklahoma City, Oklahoma

Conditions: Breast Cancer
Interventions: Research Blood Collection; Other
Lead sponsor: Abramson Cancer Center at Penn Medicine; Other
Eligibility: 18 Years and older
Enrollment: 600 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2030
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Breast Cancer
Interventions: trastuzumab, laboratory biomarker analysis, adjuvant therapy, quality-of-life assessment; Biological · Other · Procedure
Lead sponsor: Cynthia Owusu, MD; Other
Eligibility: 60 Years and older · Female only
Enrollment: 56 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2020
U.S. locations: 11
States / cities: Miami, Florida • Winston-Salem, North Carolina • Cleveland, Ohio + 3 more

Conditions: Metastatic Non-Small Cell Lung Cancer, Cancer-Associated Weight Loss, Elevated Inflammatory Markers
Interventions: Tocilizumab, Pembrolizumab, Platinum-Doublet Chemotherapy; Drug
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 18 Years and older
Enrollment: 43 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 4
States / cities: Indianapolis, Indiana • Ann Arbor, Michigan • Cleveland, Ohio + 1 more

Search by objective public record fields.

Imaging Markers of Subclinical Cardiotoxicity in Breast Cancer

Study of Dasatinib in Patients With Advanced Solid Tumors

Molecular Markers in Thyroid Cancer

A Pilot Study of Eicosapentaenoic Acid (EPA) in Patients With Cancer Cachexia

Safety and Effectiveness Study of Autologous Natural Killer and Natural Killer T Cells on Cancer

Feasibility Trial of Darwin OncoTreat and OncoTarget Precision Medicine Testing

Multi Institutional Study in Patient Presenting With Hematuria

Dovitinib (TKI258) and Abiraterone Acetate in Metastatic Castrate-Resistant Prostate Cancer (mCRPC)

S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic Breast Cancer

The Regression of Liver Fibrosis and Risk for Hepatocellular Carcinoma (ROLFH) Study

Triple Negative Breast Cancer Biomarker Study

Novel Serum Markers for Monitoring Response to Anti-Cancer Therapy

Mayo Designed Soft Tissue Ultrasound-Detectable Marker

Vitamin D, Diet and Activity Study

Markers for Breast Cancer

Effects of Bariatric Surgery on Breast Density Improvement and Impact on Breast Cancer Risk in Severe Obese Patients

cfDNA 5mC/5hmC Biomarkers to Predict Chemotherapy Response in Metastatic Colorectal Cancer

Molecular Markers and Genetic Markers in Patients Undergoing Radiation Therapy for Cancer

Feasibility of Fasting & Exercise in Pts With HR+ MBC

Pan-tumor MRD Study

Identify microRNAs in Cachexia in Pancreatic Carcinoma

PENN-Surveillance Markers of Utility for Recurrence After (Neo)Adjuvant Therapy for Breast Cancer

Trastuzumab in Treating Older Women With Early-Stage Breast Cancer

Tocilizumab Combined With First-Line Chemo-Immunotherapy in Metastatic Non-Small Cell Lung Cancer